ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Novocure (NVCR) Technical (Analysis) Reports Novocure ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Novocure (NVCR)

Technical Analysis Report for USA stock NVCR Novocure. Dated: 06 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Medical Dental Instruments in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock NVCR Novocure then click here. or read Experts views on Novocure or Forecast & share price targets of Novocure

Novocure Opened at 16.20 and Closed at: 15.69, which is -2.29% of previous session's close. It moved within a range of 15.58 and 16.20
The session was a Bearish session with an average volume of 943200, which is -30.84% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Dead cross was found 2 days back on short term averages

A Golden cross was found 6 days back on short term averages

A Dead cross was found 2 days back on mid term averages

A Golden cross was found 3 days back on mid term averages

A Golden cross was found 9 days back on mid term averages

Support for tomorrow is 15.33 and resistance for tomorrow is 15.95
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 15.45, 15.2 resistance for tomorrow's hourly charts is 16.07, 16.44

10 Day SMA for Novocure (NVCR) is 15.96 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Novocure (NVCR) is 16.24 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Novocure (NVCR) is 16.37 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 15.13 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Novocure is 13.86 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Novocure is at 16.24 and 200 DMA is at 13.86, while 50 DMA and 100 DMA are at 16.37 and 15.13 respectively

Novocure (NVCR) moving average of 20 SMA is at 16.24 and 20 EMA is at 16.15

Novocure (NVCR) moving average of 50 SMA is at 16.37 and 50 EMA is at 16.09

Novocure (NVCR) moving average of 100 SMA is at 15.13 and 100 EMA is at 15.48

Novocure (NVCR) moving average of 200 SMA is at 13.86 and 200 EMA is at 15.15

Pfizer Inc has performed better than Novocure in short term. You could have earned much better returns by investing in Pfizer Inc, about 9.52% more returns!

Laboratory Corporation has performed better than Novocure in short term. You could have earned much better returns by investing in Laboratory Corporation, about 16.89% more returns!

Novocure has performed better than Edwards Lifesciences in short term. Holding Novocure could be a better choice for now!

Novocure has performed better than Elanco Animal in short term. Holding Novocure could be a better choice for now!

Novocure has performed better than Davita Inc in short term. Holding Novocure could be a better choice for now!

Supernus Pharmaceuticals has performed better than Novocure in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 1.24% more returns!

Rhythm Pharmaceuticals has performed better than Novocure in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 6.78% more returns!

Radnet Inc has performed better than Novocure in short term. You could have earned much better returns by investing in Radnet Inc, about 10.15% more returns!

Protagonist Therapeutics has performed better than Novocure in short term. You could have earned much better returns by investing in Protagonist Therapeutics, about 15.03% more returns!

Novocure has performed better than Prothena Corporation in short term. Holding Novocure could be a better choice for now!

Novocure has performed better than Intellia Therapeutics in short term. Holding Novocure could be a better choice for now!

National Vision has performed better than Novocure in short term. You could have earned much better returns by investing in National Vision, about 18.98% more returns!

Enanta Pharmaceuticals has performed better than Novocure in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 0.29% more returns!

Novocure has performed better than Corvus Pharmaceuticals in short term. Holding Novocure could be a better choice for now!

Novocure has performed better than Alphatec Holdings in short term. Holding Novocure could be a better choice for now!

Argenx Se has performed better than Novocure in short term. You could have earned much better returns by investing in Argenx Se, about 2.38% more returns!

Amphastar Pharmaceuticals has performed better than Novocure in short term. You could have earned much better returns by investing in Amphastar Pharmaceuticals, about 5.19% more returns!

Novocure Technical analysis of indicators

Price action analysis of Novocure (NVCR) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Novocure stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Novocure in short term and the sell signal is strong.

Novocure Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Novocure in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Novocure is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 16.24 and Novocure NVCR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Novocure NVCR stock. Volume based technical analysis of Novocure NVCR stock is negative.

Novocure Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock NVCR Novocure These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And NVCR Experts View which covers a lot of information including buying and selling signals

NVCR future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Novocure or View Candle Stick Charts here

Chart Novocure (NVCR)  Technical (Analysis) Reports Novocure [

Videos related to: Novocure (NVCR) Technical (Analysis) Reports Novocure ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Novocure (NVCR)  Technical (Analysis) Reports Novocure [

 

Back to top